Telegraph Hill Partners
Telegraph Hill Partners is a venture capital firm investing in life sciences, medical device, and healthcare technology companies.
Business Model:
Revenue: $18.8M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Telegraph Hill Partners Information
Geographic Data
Address: Suite 601
City: San Francisco
State: CA
Zip: 94108
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$525M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Telegraph Hill Partners is a venture capital firm that invests behind technology leaders in the life science, medical devices, and healthcare industries. THP was founded in 2001 by J. Matthew Mackowski, Robert Shepler, Dr. Thomas Raffin, and Deval Lashkari, and is headquartered in San Francisco, California.
Contact Phone:
+14157656980
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2017 | Medpricer | Venture Round | - |
| 5/2020 | Nivagen Pharmaceuticals, Inc. | Venture Round | 16M |
| 4/2019 | Nimble Therapeutics | Series A | 10M |
| 1/2022 | Excellos | Growth | 15M |
| 1/2020 | Carterra | Venture Round | 6M |
| 11/2017 | Aquaro | Series A | 9.8M |
| 1/2003 | Estech | Series B | 5M |
| 9/2015 | Precision NanoSystem | Series A | 0 |
| 9/2007 | LDR Holding | Series C | 0 |
| 1/2007 | Althea Technologies | Series C | 23M |
| 9/2019 | Specific Diagnostics | Equity | 12.5M |
| 8/2019 | Emerging Therapy Solutions | Venture Round | 1M |
| 5/2008 | Freedom Innovations LLC. | Funding Round | - |
| 6/2006 | Asuragen | Series A | 49M |
| 3/2019 | Invisalert Solutions | Venture Round | 10M |
| 11/2021 | Cell Microsystems | Venture Round | 12.7M |
| 1/2011 | PneumRx | Venture Round | 0 |
| 12/2022 | Emerging Therapy Solutions | Venture Round | 3M |
| 12/2010 | Estech | Series D | 8.5M |
| 3/2007 | PneumRx | Series B | 0 |
| 8/2017 | RareCyte | Venture Round | 30M |
| 6/2009 | Estech | Venture Round | 0 |
| 4/2006 | AngioScore | Series D | 30M |
| 12/2007 | Asuragen | Series B | 18.5M |
| 9/2018 | Akoya Biosciences | Venture Round | 24.5M |
| 12/2019 | Akoya Biosciences | Equity | 50M |
| 7/2017 | Akoya Biosciences | Venture Round | 9M |
| 10/2007 | AngioScore | Series E | 30M |
| 1/2008 | Confirma | Series C | 0 |
| 7/2004 | Accumetrics | Series B | 0 |
| 12/2008 | Estech | Venture Round | 0 |
| 1/2018 | Carterra | Venture Round | 10M |
| 12/2020 | Carterra | Venture Round | 8.1M |
| 6/2022 | Mosaic Biosciences | Venture Round | 11.4M |
| 10/2016 | TrakCel | Venture Round | - |
| 4/2010 | AltheaDx | Series A | - |
| 8/2012 | RareCyte | Venture Round | - |
| 6/2018 | Precision NanoSystem | Series B | 6M |
| 6/2022 | Mosaic Biosciences | Venture Round | 0 |
| 1/2022 | Excellos | Funding Round | 0 |
| 11/2021 | Cell Microsystems | Venture Round | 0 |
| 12/2020 | Carterra | Venture Round | 0 |
| 5/2020 | Nivagen Pharmaceuticals, Inc. | Venture Round | 0 |
| 1/2020 | Carterra | Venture Round | 0 |
| 12/2019 | Akoya Biosciences | Series D | 0 |
| 9/2019 | Specific Diagnostics | Venture Round | 0 |
| 8/2019 | Emerging Therapy Solutions | Venture Round | 0 |
| 4/2019 | Nimble Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
